Related Experiment Videos

Bronchoalveolar lavage cell composition in allogeneic bone marrow transplant patients without symptomatic lung

R de la Cámara1, R Girón, C Marrón

  • 1Servicio de Hematología, Hospital de la Princesa, Madrid, Spain.

Bone Marrow Transplantation
|February 18, 1998
PubMed

Insights

Bronchoalveolar lavage (BAL) fluid in bone marrow transplant (BMT) patients shows increased neutrophils and lymphocytes compared to healthy individuals. Caution is advised when interpreting BAL data in BMT patients due to these differences.

Area of Science:

  • Immunology
  • Hematology
  • Pulmonology

Background:

  • Allogeneic bone marrow transplantation (BMT) can lead to pulmonary complications.
  • Understanding bronchoalveolar lavage (BAL) fluid cytology is crucial for monitoring BMT patients.
  • Baseline cytological data in BMT patients without lung issues is needed for comparison.

Purpose of the Study:

  • To analyze the cellular composition of BAL fluid in allogeneic BMT patients without lung complications.
  • To compare BAL fluid cytology between BMT patients and healthy volunteers.
  • To establish a reference range for BAL cytology in BMT recipients.

Main Methods:

  • Collected and analyzed BAL fluid samples from 56 allogeneic BMT patients within 6 months post-transplant.
  • Performed differential and total cell counts on 98 BAL samples.
  • Compared patient data with samples from healthy volunteers.

Main Results:

  • BAL fluid in BMT patients showed significantly higher neutrophils and lymphocytes compared to healthy controls.
  • Macrophages were decreased, while eosinophils remained similar between groups.
  • Increased neutrophils (neutrophilic alveolitis) were noted in patients with asymptomatic cytomegalovirus (CMV) detected via BAL.
  • Significant variability in cellular composition was observed in BMT patients.

Conclusions:

  • BAL fluid cytology differs significantly between BMT patients and healthy individuals.
  • Interpreting BAL findings in BMT patients with lung complications requires comparison with BMT controls, not healthy volunteers.
  • The distinct cellular profile in BMT patients necessitates careful consideration when diagnosing pulmonary issues post-transplant.

Related Concept Videos